Streetbeat News

Earnings

RKDA

Arcadia Biosciences, Inc. held its Q3 2024 earnings call, discussing financial results and business highlights. Key participants included CFO Mark Kawakami and CEO T.J. Schaefer.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

KINS

Kingstone Companies, Inc. (Nasdaq:KINS) reported record profitability and growth for Q3 2024 and raised its guidance for 2024 and 2025. The company will discuss these results in a conference call on November 13, 2024.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

EMBC

Embecta Corp. (Nasdaq: EMBC) will release its fiscal Q4 and full year 2024 financial results on November 26, 2024. The company will also provide an operational update and preliminary fiscal year 2025 guidance.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

HII

Levi & Korsinsky is investigating Huntington Ingalls Industries, Inc. for potential violations of federal securities laws after the company reported Q3 earnings that significantly missed analyst estimates, including a 34.2% miss on EPS.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

ALTS

ALT5 Sigma Corporation reported a record Q3 2024 with $4.94 million in revenue, driven by strong customer onboarding and upcoming launches of new capabilities for Alt5 Prime and Alt5 Pay.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

MSAI

MultiSensor AI Holdings, Inc. (NASDAQ:MSAI) announced its third quarter 2024 results, highlighting a capital raise that strengthens its balance sheet and positions the company for future growth and innovation investment.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

IHS

IHS Holding Limited held its Q3 2024 earnings call, discussing financial results for the period ending September 30, 2024. Key participants included company executives and analysts from major financial institutions.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

CLDI

Calidi Biotherapeutics Inc. (NYSE American: CLDI) reported its third quarter 2024 operating and financial results, highlighting its progress in developing targeted antitumor virotherapies.

Portfolio Pulse from

November 12, 2024 | 10:45 pm

AMAT

Applied Materials (AMAT) is set to release its fiscal fourth-quarter earnings, with Wall Street analysts showing a bullish sentiment ahead of the announcement.

Portfolio Pulse from

November 12, 2024 | 10:30 pm